| U.S. Congressional Tipoffs Involving South Carolina Newsletter for Saturday October 26, 2024 ( 1 items ) |
|
Sen. Scott Urges FDA to Address Gene Therapy Priority Voucher Discrepancy
WASHINGTON, Oct. 25 -- Sen. Tim Scott, R-South Carolina, issued the following news release:
In order to help increase treatment for sickle cell disease (SCD), U.S. Senator Tim Scott (R-S.C.) penned a letter to the Food and Drug Administration (FDA) Commissioner Robert Califf raising concerns over how the FDA interprets "active ingredient" for awarding priority review vouchers, which could negatively impact drug development for rare diseases like sickle cell disease. Senator Scott was joined on
more
|
Sign up to Receive this newsletter every day via email.